Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
2,431
archived clinical trials in
Back Pain

A Research Study of an Investigational Drug ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) in Patients With Moderate to Severe Chronic Low Back Pain
A Multicenter, 12-Week, Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Determine the Efficacy and Safety Of ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) Extended-Release Capsules in Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated:  6/27/2013
Pfizer Investigational Site
mi
from
Incline Village, NV
A Research Study of an Investigational Drug ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) in Patients With Moderate to Severe Chronic Low Back Pain
A Multicenter, 12-Week, Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Determine the Efficacy and Safety Of ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) Extended-Release Capsules in Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 6/27/2013
Pfizer Investigational Site
mi
from
Incline Village, NV
Click here to add this to my saved trials
A Research Study of an Investigational Drug ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) in Patients With Moderate to Severe Chronic Low Back Pain
A Multicenter, 12-Week, Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Determine the Efficacy and Safety Of ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) Extended-Release Capsules in Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated:  6/27/2013
Pfizer Investigational Site
mi
from
Albuquerque, NM
A Research Study of an Investigational Drug ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) in Patients With Moderate to Severe Chronic Low Back Pain
A Multicenter, 12-Week, Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Determine the Efficacy and Safety Of ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) Extended-Release Capsules in Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 6/27/2013
Pfizer Investigational Site
mi
from
Albuquerque, NM
Click here to add this to my saved trials
A Research Study of an Investigational Drug ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) in Patients With Moderate to Severe Chronic Low Back Pain
A Multicenter, 12-Week, Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Determine the Efficacy and Safety Of ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) Extended-Release Capsules in Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated:  6/27/2013
Pfizer Investigational Site
mi
from
Rochester, NY
A Research Study of an Investigational Drug ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) in Patients With Moderate to Severe Chronic Low Back Pain
A Multicenter, 12-Week, Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Determine the Efficacy and Safety Of ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) Extended-Release Capsules in Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 6/27/2013
Pfizer Investigational Site
mi
from
Rochester, NY
Click here to add this to my saved trials
A Research Study of an Investigational Drug ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) in Patients With Moderate to Severe Chronic Low Back Pain
A Multicenter, 12-Week, Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Determine the Efficacy and Safety Of ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) Extended-Release Capsules in Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated:  6/27/2013
Pfizer Investigational Site
mi
from
Asheville, NC
A Research Study of an Investigational Drug ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) in Patients With Moderate to Severe Chronic Low Back Pain
A Multicenter, 12-Week, Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Determine the Efficacy and Safety Of ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) Extended-Release Capsules in Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 6/27/2013
Pfizer Investigational Site
mi
from
Asheville, NC
Click here to add this to my saved trials
A Research Study of an Investigational Drug ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) in Patients With Moderate to Severe Chronic Low Back Pain
A Multicenter, 12-Week, Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Determine the Efficacy and Safety Of ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) Extended-Release Capsules in Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated:  6/27/2013
Pfizer Investigational Site
mi
from
Akron, OH
A Research Study of an Investigational Drug ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) in Patients With Moderate to Severe Chronic Low Back Pain
A Multicenter, 12-Week, Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Determine the Efficacy and Safety Of ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) Extended-Release Capsules in Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 6/27/2013
Pfizer Investigational Site
mi
from
Akron, OH
Click here to add this to my saved trials
A Research Study of an Investigational Drug ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) in Patients With Moderate to Severe Chronic Low Back Pain
A Multicenter, 12-Week, Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Determine the Efficacy and Safety Of ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) Extended-Release Capsules in Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated:  6/27/2013
Pfizer Investigational Site
mi
from
Norman, OK
A Research Study of an Investigational Drug ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) in Patients With Moderate to Severe Chronic Low Back Pain
A Multicenter, 12-Week, Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Determine the Efficacy and Safety Of ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) Extended-Release Capsules in Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 6/27/2013
Pfizer Investigational Site
mi
from
Norman, OK
Click here to add this to my saved trials
A Research Study of an Investigational Drug ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) in Patients With Moderate to Severe Chronic Low Back Pain
A Multicenter, 12-Week, Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Determine the Efficacy and Safety Of ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) Extended-Release Capsules in Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated:  6/27/2013
Pfizer Investigational Site
mi
from
Pittsburgh, PA
A Research Study of an Investigational Drug ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) in Patients With Moderate to Severe Chronic Low Back Pain
A Multicenter, 12-Week, Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Determine the Efficacy and Safety Of ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) Extended-Release Capsules in Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 6/27/2013
Pfizer Investigational Site
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
A Research Study of an Investigational Drug ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) in Patients With Moderate to Severe Chronic Low Back Pain
A Multicenter, 12-Week, Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Determine the Efficacy and Safety Of ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) Extended-Release Capsules in Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated:  6/27/2013
Pfizer Investigational Site
mi
from
Cranston, RI
A Research Study of an Investigational Drug ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) in Patients With Moderate to Severe Chronic Low Back Pain
A Multicenter, 12-Week, Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Determine the Efficacy and Safety Of ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) Extended-Release Capsules in Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 6/27/2013
Pfizer Investigational Site
mi
from
Cranston, RI
Click here to add this to my saved trials
A Research Study of an Investigational Drug ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) in Patients With Moderate to Severe Chronic Low Back Pain
A Multicenter, 12-Week, Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Determine the Efficacy and Safety Of ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) Extended-Release Capsules in Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated:  6/27/2013
Pfizer Investigational Site
mi
from
Anderson, SC
A Research Study of an Investigational Drug ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) in Patients With Moderate to Severe Chronic Low Back Pain
A Multicenter, 12-Week, Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Determine the Efficacy and Safety Of ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) Extended-Release Capsules in Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 6/27/2013
Pfizer Investigational Site
mi
from
Anderson, SC
Click here to add this to my saved trials
A Research Study of an Investigational Drug ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) in Patients With Moderate to Severe Chronic Low Back Pain
A Multicenter, 12-Week, Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Determine the Efficacy and Safety Of ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) Extended-Release Capsules in Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated:  6/27/2013
Pfizer Investigational Site
mi
from
Houston, TX
A Research Study of an Investigational Drug ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) in Patients With Moderate to Severe Chronic Low Back Pain
A Multicenter, 12-Week, Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Determine the Efficacy and Safety Of ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) Extended-Release Capsules in Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 6/27/2013
Pfizer Investigational Site
mi
from
Houston, TX
Click here to add this to my saved trials
Trial of Scrambler Therapy or Sham Treatment for Low Back Pain
A Pilot Randomized Trial of Scrambler Therapy or Sham Treatment for Persistent Nonspecific Low Back Pain
Status: Enrolling
Updated:  7/10/2013
Virginia Commonwealth University School of Nursing
mi
from
Richmond, VA
Trial of Scrambler Therapy or Sham Treatment for Low Back Pain
A Pilot Randomized Trial of Scrambler Therapy or Sham Treatment for Persistent Nonspecific Low Back Pain
Status: Enrolling
Updated: 7/10/2013
Virginia Commonwealth University School of Nursing
mi
from
Richmond, VA
Click here to add this to my saved trials
Comparison of Extensible and Inextensible Lumbosacral Orthoses for Lower Back Pain
Comparison of Inextensible and Extensible Lumbosacral Orthoses for the Management of Episodes of Lower Back Pain
Status: Enrolling
Updated:  8/28/2013
Medical University of South Carolina
mi
from
Charleston, SC
Comparison of Extensible and Inextensible Lumbosacral Orthoses for Lower Back Pain
Comparison of Inextensible and Extensible Lumbosacral Orthoses for the Management of Episodes of Lower Back Pain
Status: Enrolling
Updated: 8/28/2013
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Clinical Prediction Rule for Clinical Lumbar Instability
Identifying the Subgroup of Patient With Mechanical Low Back Pain Who Have Clinical Lumbar Instability
Status: Enrolling
Updated:  8/30/2013
Drexel University
mi
from
Phildadelphia, PA
Clinical Prediction Rule for Clinical Lumbar Instability
Identifying the Subgroup of Patient With Mechanical Low Back Pain Who Have Clinical Lumbar Instability
Status: Enrolling
Updated: 8/30/2013
Drexel University
mi
from
Phildadelphia, PA
Click here to add this to my saved trials
Clinical Prediction Rule for Clinical Lumbar Instability
Identifying the Subgroup of Patient With Mechanical Low Back Pain Who Have Clinical Lumbar Instability
Status: Enrolling
Updated:  8/30/2013
Optimum Physical Therapy Associates
mi
from
West Chester, PA
Clinical Prediction Rule for Clinical Lumbar Instability
Identifying the Subgroup of Patient With Mechanical Low Back Pain Who Have Clinical Lumbar Instability
Status: Enrolling
Updated: 8/30/2013
Optimum Physical Therapy Associates
mi
from
West Chester, PA
Click here to add this to my saved trials
Buprenorphine and Methadone for Opioid-dependent Chronic Back Pain Patients
A Randomized Controlled Trial Comparing Buprenorphine and Methadone for Treatment in Opioid Dependent Chronic Back Pain Patients
Status: Enrolling
Updated:  8/30/2013
UB/MD Family Medicine, Inc.
mi
from
Amherst, NY
Buprenorphine and Methadone for Opioid-dependent Chronic Back Pain Patients
A Randomized Controlled Trial Comparing Buprenorphine and Methadone for Treatment in Opioid Dependent Chronic Back Pain Patients
Status: Enrolling
Updated: 8/30/2013
UB/MD Family Medicine, Inc.
mi
from
Amherst, NY
Click here to add this to my saved trials
Sub-Sensory Intraspinal Neurostimulation Therapy
Sub-Sensory Intraspinal Neurostimulation Therapy In the Treatment of Neuropathic Back and/or Leg Pain
Status: Enrolling
Updated:  10/30/2013
Comprehensive Pain & Rehabilitation
mi
from
Pascagoula, MS
Sub-Sensory Intraspinal Neurostimulation Therapy
Sub-Sensory Intraspinal Neurostimulation Therapy In the Treatment of Neuropathic Back and/or Leg Pain
Status: Enrolling
Updated: 10/30/2013
Comprehensive Pain & Rehabilitation
mi
from
Pascagoula, MS
Click here to add this to my saved trials
Prescriptive Mobilization Versus a Pragmatic Mobilization
The Investigation of a Prescriptively Prescribed Non-Thrust Manipulation Versus a Pragmatically Prescribed Non-Thrust Manipulation for Treatment of Individuals With Low Back Pain: A Randomized Controlled Trial
Status: Enrolling
Updated:  11/8/2013
Des Moines University
mi
from
Des Moines, IA
Prescriptive Mobilization Versus a Pragmatic Mobilization
The Investigation of a Prescriptively Prescribed Non-Thrust Manipulation Versus a Pragmatically Prescribed Non-Thrust Manipulation for Treatment of Individuals With Low Back Pain: A Randomized Controlled Trial
Status: Enrolling
Updated: 11/8/2013
Des Moines University
mi
from
Des Moines, IA
Click here to add this to my saved trials
Prescriptive Mobilization Versus a Pragmatic Mobilization
The Investigation of a Prescriptively Prescribed Non-Thrust Manipulation Versus a Pragmatically Prescribed Non-Thrust Manipulation for Treatment of Individuals With Low Back Pain: A Randomized Controlled Trial
Status: Enrolling
Updated:  11/8/2013
Walsh University
mi
from
North Canton, OH
Prescriptive Mobilization Versus a Pragmatic Mobilization
The Investigation of a Prescriptively Prescribed Non-Thrust Manipulation Versus a Pragmatically Prescribed Non-Thrust Manipulation for Treatment of Individuals With Low Back Pain: A Randomized Controlled Trial
Status: Enrolling
Updated: 11/8/2013
Walsh University
mi
from
North Canton, OH
Click here to add this to my saved trials
Prescriptive Mobilization Versus a Pragmatic Mobilization
The Investigation of a Prescriptively Prescribed Non-Thrust Manipulation Versus a Pragmatically Prescribed Non-Thrust Manipulation for Treatment of Individuals With Low Back Pain: A Randomized Controlled Trial
Status: Enrolling
Updated:  11/8/2013
Youngstown State University
mi
from
Youngstown, OH
Prescriptive Mobilization Versus a Pragmatic Mobilization
The Investigation of a Prescriptively Prescribed Non-Thrust Manipulation Versus a Pragmatically Prescribed Non-Thrust Manipulation for Treatment of Individuals With Low Back Pain: A Randomized Controlled Trial
Status: Enrolling
Updated: 11/8/2013
Youngstown State University
mi
from
Youngstown, OH
Click here to add this to my saved trials
SMART Clinical Study: Surgical Multi-center Assessment of RF Ablation for the Treatment of Vertebrogenic Back Pain
A Prospective Randomized, Double-blind, Controlled Investigation Evaluating the Intracept Intraosseous Nerve Ablation System for the Reduction of Pain in Patients With Chronic Axial Low Back Pain
Status: Enrolling
Updated:  11/12/2013
Desert Institute for Spine Care
mi
from
Phoenix, AZ
SMART Clinical Study: Surgical Multi-center Assessment of RF Ablation for the Treatment of Vertebrogenic Back Pain
A Prospective Randomized, Double-blind, Controlled Investigation Evaluating the Intracept Intraosseous Nerve Ablation System for the Reduction of Pain in Patients With Chronic Axial Low Back Pain
Status: Enrolling
Updated: 11/12/2013
Desert Institute for Spine Care
mi
from
Phoenix, AZ
Click here to add this to my saved trials
SMART Clinical Study: Surgical Multi-center Assessment of RF Ablation for the Treatment of Vertebrogenic Back Pain
A Prospective Randomized, Double-blind, Controlled Investigation Evaluating the Intracept Intraosseous Nerve Ablation System for the Reduction of Pain in Patients With Chronic Axial Low Back Pain
Status: Enrolling
Updated:  11/12/2013
SpineCare Medical Group
mi
from
Daly City, CA
SMART Clinical Study: Surgical Multi-center Assessment of RF Ablation for the Treatment of Vertebrogenic Back Pain
A Prospective Randomized, Double-blind, Controlled Investigation Evaluating the Intracept Intraosseous Nerve Ablation System for the Reduction of Pain in Patients With Chronic Axial Low Back Pain
Status: Enrolling
Updated: 11/12/2013
SpineCare Medical Group
mi
from
Daly City, CA
Click here to add this to my saved trials
SMART Clinical Study: Surgical Multi-center Assessment of RF Ablation for the Treatment of Vertebrogenic Back Pain
A Prospective Randomized, Double-blind, Controlled Investigation Evaluating the Intracept Intraosseous Nerve Ablation System for the Reduction of Pain in Patients With Chronic Axial Low Back Pain
Status: Enrolling
Updated:  11/12/2013
Memorial Orthopedic Surgical Group
mi
from
Long Beach, CA
SMART Clinical Study: Surgical Multi-center Assessment of RF Ablation for the Treatment of Vertebrogenic Back Pain
A Prospective Randomized, Double-blind, Controlled Investigation Evaluating the Intracept Intraosseous Nerve Ablation System for the Reduction of Pain in Patients With Chronic Axial Low Back Pain
Status: Enrolling
Updated: 11/12/2013
Memorial Orthopedic Surgical Group
mi
from
Long Beach, CA
Click here to add this to my saved trials
SMART Clinical Study: Surgical Multi-center Assessment of RF Ablation for the Treatment of Vertebrogenic Back Pain
A Prospective Randomized, Double-blind, Controlled Investigation Evaluating the Intracept Intraosseous Nerve Ablation System for the Reduction of Pain in Patients With Chronic Axial Low Back Pain
Status: Enrolling
Updated:  11/12/2013
The Spine Institute
mi
from
Santa Monica, CA
SMART Clinical Study: Surgical Multi-center Assessment of RF Ablation for the Treatment of Vertebrogenic Back Pain
A Prospective Randomized, Double-blind, Controlled Investigation Evaluating the Intracept Intraosseous Nerve Ablation System for the Reduction of Pain in Patients With Chronic Axial Low Back Pain
Status: Enrolling
Updated: 11/12/2013
The Spine Institute
mi
from
Santa Monica, CA
Click here to add this to my saved trials
SMART Clinical Study: Surgical Multi-center Assessment of RF Ablation for the Treatment of Vertebrogenic Back Pain
A Prospective Randomized, Double-blind, Controlled Investigation Evaluating the Intracept Intraosseous Nerve Ablation System for the Reduction of Pain in Patients With Chronic Axial Low Back Pain
Status: Enrolling
Updated:  11/12/2013
Pain Center Solutions
mi
from
Marietta, GA
SMART Clinical Study: Surgical Multi-center Assessment of RF Ablation for the Treatment of Vertebrogenic Back Pain
A Prospective Randomized, Double-blind, Controlled Investigation Evaluating the Intracept Intraosseous Nerve Ablation System for the Reduction of Pain in Patients With Chronic Axial Low Back Pain
Status: Enrolling
Updated: 11/12/2013
Pain Center Solutions
mi
from
Marietta, GA
Click here to add this to my saved trials
SMART Clinical Study: Surgical Multi-center Assessment of RF Ablation for the Treatment of Vertebrogenic Back Pain
A Prospective Randomized, Double-blind, Controlled Investigation Evaluating the Intracept Intraosseous Nerve Ablation System for the Reduction of Pain in Patients With Chronic Axial Low Back Pain
Status: Enrolling
Updated:  11/12/2013
Indiana Spine Group
mi
from
Carmel, IN
SMART Clinical Study: Surgical Multi-center Assessment of RF Ablation for the Treatment of Vertebrogenic Back Pain
A Prospective Randomized, Double-blind, Controlled Investigation Evaluating the Intracept Intraosseous Nerve Ablation System for the Reduction of Pain in Patients With Chronic Axial Low Back Pain
Status: Enrolling
Updated: 11/12/2013
Indiana Spine Group
mi
from
Carmel, IN
Click here to add this to my saved trials
SMART Clinical Study: Surgical Multi-center Assessment of RF Ablation for the Treatment of Vertebrogenic Back Pain
A Prospective Randomized, Double-blind, Controlled Investigation Evaluating the Intracept Intraosseous Nerve Ablation System for the Reduction of Pain in Patients With Chronic Axial Low Back Pain
Status: Enrolling
Updated:  11/12/2013
Maine Medical Partners
mi
from
Scarborough, ME
SMART Clinical Study: Surgical Multi-center Assessment of RF Ablation for the Treatment of Vertebrogenic Back Pain
A Prospective Randomized, Double-blind, Controlled Investigation Evaluating the Intracept Intraosseous Nerve Ablation System for the Reduction of Pain in Patients With Chronic Axial Low Back Pain
Status: Enrolling
Updated: 11/12/2013
Maine Medical Partners
mi
from
Scarborough, ME
Click here to add this to my saved trials
SMART Clinical Study: Surgical Multi-center Assessment of RF Ablation for the Treatment of Vertebrogenic Back Pain
A Prospective Randomized, Double-blind, Controlled Investigation Evaluating the Intracept Intraosseous Nerve Ablation System for the Reduction of Pain in Patients With Chronic Axial Low Back Pain
Status: Enrolling
Updated:  11/12/2013
Partners in Research and Educational Studies of Spinal Disorders (PressD)
mi
from
Southfield, MI
SMART Clinical Study: Surgical Multi-center Assessment of RF Ablation for the Treatment of Vertebrogenic Back Pain
A Prospective Randomized, Double-blind, Controlled Investigation Evaluating the Intracept Intraosseous Nerve Ablation System for the Reduction of Pain in Patients With Chronic Axial Low Back Pain
Status: Enrolling
Updated: 11/12/2013
Partners in Research and Educational Studies of Spinal Disorders (PressD)
mi
from
Southfield, MI
Click here to add this to my saved trials
SMART Clinical Study: Surgical Multi-center Assessment of RF Ablation for the Treatment of Vertebrogenic Back Pain
A Prospective Randomized, Double-blind, Controlled Investigation Evaluating the Intracept Intraosseous Nerve Ablation System for the Reduction of Pain in Patients With Chronic Axial Low Back Pain
Status: Enrolling
Updated:  11/12/2013
OrthoCarolina
mi
from
Charlotte, NC
SMART Clinical Study: Surgical Multi-center Assessment of RF Ablation for the Treatment of Vertebrogenic Back Pain
A Prospective Randomized, Double-blind, Controlled Investigation Evaluating the Intracept Intraosseous Nerve Ablation System for the Reduction of Pain in Patients With Chronic Axial Low Back Pain
Status: Enrolling
Updated: 11/12/2013
OrthoCarolina
mi
from
Charlotte, NC
Click here to add this to my saved trials
SMART Clinical Study: Surgical Multi-center Assessment of RF Ablation for the Treatment of Vertebrogenic Back Pain
A Prospective Randomized, Double-blind, Controlled Investigation Evaluating the Intracept Intraosseous Nerve Ablation System for the Reduction of Pain in Patients With Chronic Axial Low Back Pain
Status: Enrolling
Updated:  11/12/2013
NeuroSpine Institute LLC
mi
from
Eugene, OR
SMART Clinical Study: Surgical Multi-center Assessment of RF Ablation for the Treatment of Vertebrogenic Back Pain
A Prospective Randomized, Double-blind, Controlled Investigation Evaluating the Intracept Intraosseous Nerve Ablation System for the Reduction of Pain in Patients With Chronic Axial Low Back Pain
Status: Enrolling
Updated: 11/12/2013
NeuroSpine Institute LLC
mi
from
Eugene, OR
Click here to add this to my saved trials
SMART Clinical Study: Surgical Multi-center Assessment of RF Ablation for the Treatment of Vertebrogenic Back Pain
A Prospective Randomized, Double-blind, Controlled Investigation Evaluating the Intracept Intraosseous Nerve Ablation System for the Reduction of Pain in Patients With Chronic Axial Low Back Pain
Status: Enrolling
Updated:  11/12/2013
Rothman Institute
mi
from
Philadelphia, PA
SMART Clinical Study: Surgical Multi-center Assessment of RF Ablation for the Treatment of Vertebrogenic Back Pain
A Prospective Randomized, Double-blind, Controlled Investigation Evaluating the Intracept Intraosseous Nerve Ablation System for the Reduction of Pain in Patients With Chronic Axial Low Back Pain
Status: Enrolling
Updated: 11/12/2013
Rothman Institute
mi
from
Philadelphia, PA
Click here to add this to my saved trials
SMART Clinical Study: Surgical Multi-center Assessment of RF Ablation for the Treatment of Vertebrogenic Back Pain
A Prospective Randomized, Double-blind, Controlled Investigation Evaluating the Intracept Intraosseous Nerve Ablation System for the Reduction of Pain in Patients With Chronic Axial Low Back Pain
Status: Enrolling
Updated:  11/12/2013
Seton Spine & Scoliosis Center
mi
from
Austin, TX
SMART Clinical Study: Surgical Multi-center Assessment of RF Ablation for the Treatment of Vertebrogenic Back Pain
A Prospective Randomized, Double-blind, Controlled Investigation Evaluating the Intracept Intraosseous Nerve Ablation System for the Reduction of Pain in Patients With Chronic Axial Low Back Pain
Status: Enrolling
Updated: 11/12/2013
Seton Spine & Scoliosis Center
mi
from
Austin, TX
Click here to add this to my saved trials
SMART Clinical Study: Surgical Multi-center Assessment of RF Ablation for the Treatment of Vertebrogenic Back Pain
A Prospective Randomized, Double-blind, Controlled Investigation Evaluating the Intracept Intraosseous Nerve Ablation System for the Reduction of Pain in Patients With Chronic Axial Low Back Pain
Status: Enrolling
Updated:  11/12/2013
Virginia iSpine Physicians
mi
from
Richmond, VA
SMART Clinical Study: Surgical Multi-center Assessment of RF Ablation for the Treatment of Vertebrogenic Back Pain
A Prospective Randomized, Double-blind, Controlled Investigation Evaluating the Intracept Intraosseous Nerve Ablation System for the Reduction of Pain in Patients With Chronic Axial Low Back Pain
Status: Enrolling
Updated: 11/12/2013
Virginia iSpine Physicians
mi
from
Richmond, VA
Click here to add this to my saved trials
PRoGReSS-PS: Patient Response to GRraded Sensory Stimulation: A Pilot Study
PRoGReSS-PS: Patient Response to GRraded Sensory Stimulation: A Pilot Randomized Controlled Trial
Status: Enrolling
Updated:  11/13/2013
Palmer Center for Chiropractic Research
mi
from
Davenport, IA
PRoGReSS-PS: Patient Response to GRraded Sensory Stimulation: A Pilot Study
PRoGReSS-PS: Patient Response to GRraded Sensory Stimulation: A Pilot Randomized Controlled Trial
Status: Enrolling
Updated: 11/13/2013
Palmer Center for Chiropractic Research
mi
from
Davenport, IA
Click here to add this to my saved trials
Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets for Moderate to Severe Chronic Low Back Pain
A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Randomized-Withdrawal Study to Evaluate the Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) at 30 to 90 mg Every 12 Hours for Relief of Chronic Low Back Pain Who Require Opioid Treatment for an Extended Period of Time
Status: Enrolling
Updated:  11/15/2013
Teva Investigational Site 10416
mi
from
Anniston, AL
Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets for Moderate to Severe Chronic Low Back Pain
A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Randomized-Withdrawal Study to Evaluate the Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) at 30 to 90 mg Every 12 Hours for Relief of Chronic Low Back Pain Who Require Opioid Treatment for an Extended Period of Time
Status: Enrolling
Updated: 11/15/2013
Teva Investigational Site 10416
mi
from
Anniston, AL
Click here to add this to my saved trials
Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets for Moderate to Severe Chronic Low Back Pain
A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Randomized-Withdrawal Study to Evaluate the Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) at 30 to 90 mg Every 12 Hours for Relief of Chronic Low Back Pain Who Require Opioid Treatment for an Extended Period of Time
Status: Enrolling
Updated:  11/15/2013
Teva Investigational Site
mi
from
Birmingham, AL
Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets for Moderate to Severe Chronic Low Back Pain
A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Randomized-Withdrawal Study to Evaluate the Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) at 30 to 90 mg Every 12 Hours for Relief of Chronic Low Back Pain Who Require Opioid Treatment for an Extended Period of Time
Status: Enrolling
Updated: 11/15/2013
Teva Investigational Site
mi
from
Birmingham, AL
Click here to add this to my saved trials
Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets for Moderate to Severe Chronic Low Back Pain
A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Randomized-Withdrawal Study to Evaluate the Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) at 30 to 90 mg Every 12 Hours for Relief of Chronic Low Back Pain Who Require Opioid Treatment for an Extended Period of Time
Status: Enrolling
Updated:  11/15/2013
Teva Investigational Site 10426
mi
from
Mobile, AL
Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets for Moderate to Severe Chronic Low Back Pain
A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Randomized-Withdrawal Study to Evaluate the Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) at 30 to 90 mg Every 12 Hours for Relief of Chronic Low Back Pain Who Require Opioid Treatment for an Extended Period of Time
Status: Enrolling
Updated: 11/15/2013
Teva Investigational Site 10426
mi
from
Mobile, AL
Click here to add this to my saved trials
Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets for Moderate to Severe Chronic Low Back Pain
A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Randomized-Withdrawal Study to Evaluate the Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) at 30 to 90 mg Every 12 Hours for Relief of Chronic Low Back Pain Who Require Opioid Treatment for an Extended Period of Time
Status: Enrolling
Updated:  11/15/2013
Teva Investigational Site
mi
from
Montgomery, AL
Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets for Moderate to Severe Chronic Low Back Pain
A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Randomized-Withdrawal Study to Evaluate the Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) at 30 to 90 mg Every 12 Hours for Relief of Chronic Low Back Pain Who Require Opioid Treatment for an Extended Period of Time
Status: Enrolling
Updated: 11/15/2013
Teva Investigational Site
mi
from
Montgomery, AL
Click here to add this to my saved trials
Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets for Moderate to Severe Chronic Low Back Pain
A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Randomized-Withdrawal Study to Evaluate the Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) at 30 to 90 mg Every 12 Hours for Relief of Chronic Low Back Pain Who Require Opioid Treatment for an Extended Period of Time
Status: Enrolling
Updated:  11/15/2013
Teva Investigational Site 34
mi
from
Phoenix, AZ
Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets for Moderate to Severe Chronic Low Back Pain
A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Randomized-Withdrawal Study to Evaluate the Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) at 30 to 90 mg Every 12 Hours for Relief of Chronic Low Back Pain Who Require Opioid Treatment for an Extended Period of Time
Status: Enrolling
Updated: 11/15/2013
Teva Investigational Site 34
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets for Moderate to Severe Chronic Low Back Pain
A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Randomized-Withdrawal Study to Evaluate the Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) at 30 to 90 mg Every 12 Hours for Relief of Chronic Low Back Pain Who Require Opioid Treatment for an Extended Period of Time
Status: Enrolling
Updated:  11/15/2013
Teva Investigational Site 10276
mi
from
Tucson, AZ
Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets for Moderate to Severe Chronic Low Back Pain
A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Randomized-Withdrawal Study to Evaluate the Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) at 30 to 90 mg Every 12 Hours for Relief of Chronic Low Back Pain Who Require Opioid Treatment for an Extended Period of Time
Status: Enrolling
Updated: 11/15/2013
Teva Investigational Site 10276
mi
from
Tucson, AZ
Click here to add this to my saved trials
Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets for Moderate to Severe Chronic Low Back Pain
A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Randomized-Withdrawal Study to Evaluate the Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) at 30 to 90 mg Every 12 Hours for Relief of Chronic Low Back Pain Who Require Opioid Treatment for an Extended Period of Time
Status: Enrolling
Updated:  11/15/2013
Teva Investigational Site 10358
mi
from
Anaheim, CA
Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets for Moderate to Severe Chronic Low Back Pain
A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Randomized-Withdrawal Study to Evaluate the Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) at 30 to 90 mg Every 12 Hours for Relief of Chronic Low Back Pain Who Require Opioid Treatment for an Extended Period of Time
Status: Enrolling
Updated: 11/15/2013
Teva Investigational Site 10358
mi
from
Anaheim, CA
Click here to add this to my saved trials
Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets for Moderate to Severe Chronic Low Back Pain
A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Randomized-Withdrawal Study to Evaluate the Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) at 30 to 90 mg Every 12 Hours for Relief of Chronic Low Back Pain Who Require Opioid Treatment for an Extended Period of Time
Status: Enrolling
Updated:  11/15/2013
Teva Investigational Site 10408
mi
from
Bell Gardens, CA
Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets for Moderate to Severe Chronic Low Back Pain
A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Randomized-Withdrawal Study to Evaluate the Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) at 30 to 90 mg Every 12 Hours for Relief of Chronic Low Back Pain Who Require Opioid Treatment for an Extended Period of Time
Status: Enrolling
Updated: 11/15/2013
Teva Investigational Site 10408
mi
from
Bell Gardens, CA
Click here to add this to my saved trials
Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets for Moderate to Severe Chronic Low Back Pain
A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Randomized-Withdrawal Study to Evaluate the Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) at 30 to 90 mg Every 12 Hours for Relief of Chronic Low Back Pain Who Require Opioid Treatment for an Extended Period of Time
Status: Enrolling
Updated:  11/15/2013
Teva Investigational Site 10425
mi
from
Carmichael, CA
Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets for Moderate to Severe Chronic Low Back Pain
A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Randomized-Withdrawal Study to Evaluate the Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) at 30 to 90 mg Every 12 Hours for Relief of Chronic Low Back Pain Who Require Opioid Treatment for an Extended Period of Time
Status: Enrolling
Updated: 11/15/2013
Teva Investigational Site 10425
mi
from
Carmichael, CA
Click here to add this to my saved trials
Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets for Moderate to Severe Chronic Low Back Pain
A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Randomized-Withdrawal Study to Evaluate the Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) at 30 to 90 mg Every 12 Hours for Relief of Chronic Low Back Pain Who Require Opioid Treatment for an Extended Period of Time
Status: Enrolling
Updated:  11/15/2013
Teva Investigational Site 10390
mi
from
Cerritos, CA
Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets for Moderate to Severe Chronic Low Back Pain
A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Randomized-Withdrawal Study to Evaluate the Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) at 30 to 90 mg Every 12 Hours for Relief of Chronic Low Back Pain Who Require Opioid Treatment for an Extended Period of Time
Status: Enrolling
Updated: 11/15/2013
Teva Investigational Site 10390
mi
from
Cerritos, CA
Click here to add this to my saved trials
Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets for Moderate to Severe Chronic Low Back Pain
A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Randomized-Withdrawal Study to Evaluate the Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) at 30 to 90 mg Every 12 Hours for Relief of Chronic Low Back Pain Who Require Opioid Treatment for an Extended Period of Time
Status: Enrolling
Updated:  11/15/2013
Teva Investigational Site 10429
mi
from
El Cajon, CA
Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets for Moderate to Severe Chronic Low Back Pain
A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Randomized-Withdrawal Study to Evaluate the Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) at 30 to 90 mg Every 12 Hours for Relief of Chronic Low Back Pain Who Require Opioid Treatment for an Extended Period of Time
Status: Enrolling
Updated: 11/15/2013
Teva Investigational Site 10429
mi
from
El Cajon, CA
Click here to add this to my saved trials
Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets for Moderate to Severe Chronic Low Back Pain
A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Randomized-Withdrawal Study to Evaluate the Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) at 30 to 90 mg Every 12 Hours for Relief of Chronic Low Back Pain Who Require Opioid Treatment for an Extended Period of Time
Status: Enrolling
Updated:  11/15/2013
Teva Investigational Site 10423
mi
from
Escondido, CA
Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets for Moderate to Severe Chronic Low Back Pain
A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Randomized-Withdrawal Study to Evaluate the Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) at 30 to 90 mg Every 12 Hours for Relief of Chronic Low Back Pain Who Require Opioid Treatment for an Extended Period of Time
Status: Enrolling
Updated: 11/15/2013
Teva Investigational Site 10423
mi
from
Escondido, CA
Click here to add this to my saved trials
Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets for Moderate to Severe Chronic Low Back Pain
A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Randomized-Withdrawal Study to Evaluate the Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) at 30 to 90 mg Every 12 Hours for Relief of Chronic Low Back Pain Who Require Opioid Treatment for an Extended Period of Time
Status: Enrolling
Updated:  11/15/2013
Teva Investigational Site 10740
mi
from
Garden Grove, CA
Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets for Moderate to Severe Chronic Low Back Pain
A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Randomized-Withdrawal Study to Evaluate the Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) at 30 to 90 mg Every 12 Hours for Relief of Chronic Low Back Pain Who Require Opioid Treatment for an Extended Period of Time
Status: Enrolling
Updated: 11/15/2013
Teva Investigational Site 10740
mi
from
Garden Grove, CA
Click here to add this to my saved trials
Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets for Moderate to Severe Chronic Low Back Pain
A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Randomized-Withdrawal Study to Evaluate the Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) at 30 to 90 mg Every 12 Hours for Relief of Chronic Low Back Pain Who Require Opioid Treatment for an Extended Period of Time
Status: Enrolling
Updated:  11/15/2013
Teva Investigational Site 10391
mi
from
Huntington Park, CA
Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets for Moderate to Severe Chronic Low Back Pain
A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Randomized-Withdrawal Study to Evaluate the Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) at 30 to 90 mg Every 12 Hours for Relief of Chronic Low Back Pain Who Require Opioid Treatment for an Extended Period of Time
Status: Enrolling
Updated: 11/15/2013
Teva Investigational Site 10391
mi
from
Huntington Park, CA
Click here to add this to my saved trials
Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets for Moderate to Severe Chronic Low Back Pain
A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Randomized-Withdrawal Study to Evaluate the Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) at 30 to 90 mg Every 12 Hours for Relief of Chronic Low Back Pain Who Require Opioid Treatment for an Extended Period of Time
Status: Enrolling
Updated:  11/15/2013
Teva Investigational Site 04
mi
from
La Jolla, CA
Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets for Moderate to Severe Chronic Low Back Pain
A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Randomized-Withdrawal Study to Evaluate the Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) at 30 to 90 mg Every 12 Hours for Relief of Chronic Low Back Pain Who Require Opioid Treatment for an Extended Period of Time
Status: Enrolling
Updated: 11/15/2013
Teva Investigational Site 04
mi
from
La Jolla, CA
Click here to add this to my saved trials
Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets for Moderate to Severe Chronic Low Back Pain
A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Randomized-Withdrawal Study to Evaluate the Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) at 30 to 90 mg Every 12 Hours for Relief of Chronic Low Back Pain Who Require Opioid Treatment for an Extended Period of Time
Status: Enrolling
Updated:  11/15/2013
Teva Investigational Site 10442
mi
from
Laguna Hill, CA
Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets for Moderate to Severe Chronic Low Back Pain
A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Randomized-Withdrawal Study to Evaluate the Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) at 30 to 90 mg Every 12 Hours for Relief of Chronic Low Back Pain Who Require Opioid Treatment for an Extended Period of Time
Status: Enrolling
Updated: 11/15/2013
Teva Investigational Site 10442
mi
from
Laguna Hill, CA
Click here to add this to my saved trials
Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets for Moderate to Severe Chronic Low Back Pain
A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Randomized-Withdrawal Study to Evaluate the Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) at 30 to 90 mg Every 12 Hours for Relief of Chronic Low Back Pain Who Require Opioid Treatment for an Extended Period of Time
Status: Enrolling
Updated:  11/15/2013
Teva Investigational Site 10413
mi
from
Laguna Hills, CA
Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets for Moderate to Severe Chronic Low Back Pain
A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Randomized-Withdrawal Study to Evaluate the Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) at 30 to 90 mg Every 12 Hours for Relief of Chronic Low Back Pain Who Require Opioid Treatment for an Extended Period of Time
Status: Enrolling
Updated: 11/15/2013
Teva Investigational Site 10413
mi
from
Laguna Hills, CA
Click here to add this to my saved trials